These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 4405377

  • 1. Clinical pharmacological evaluation of beta-receptor antagonists. II. The influence on the effect of isuprel by propranolol, oxprenolol, alprenolol in patients with essential circulatory hyperkinesis (ECH).
    Bekes M, Matos L, Rausch J, Török E.
    Int J Clin Pharmacol; 1972 Aug; 6(3):209-13. PubMed ID: 4405377
    [No Abstract] [Full Text] [Related]

  • 2. Clinical pharmacological evaluation of beta-receptor antagonists. I. The effect of propranolol, oxprenolol, alprenolol on some central circulatory parameters in patients with essential circulatory hyperkinesis (ECH).
    Békés M, Matos L, Rausch J, Török E.
    Int J Clin Pharmacol; 1972 Jun; 6(2):161-6. PubMed ID: 4404774
    [No Abstract] [Full Text] [Related]

  • 3. [Arrhythmia action and cardiovascular effects of a new beta-adrenergic blockader (Oxprenolol)].
    Suzuki K, Kubota M, Odashiro M, Yasuda K, Goto Y.
    Masui; 1972 Jan; 21(1):46-50. PubMed ID: 4401935
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of beta-adrenergic blocking activities of propranolol, isopropylmethoxamine, sotalol, practolol, alprenolol, pindolol, oxprenolol and D-32 in the atria and trachea of the guinea-pig.
    Horii D, Kawada T, Takeda K, Imai S.
    Arzneimittelforschung; 1974 Sep; 24(9):1275-7. PubMed ID: 4154764
    [No Abstract] [Full Text] [Related]

  • 5. [Cardiovascular effects of propanolol, alprenolol, oxprenolol and CS-359 during halothane anesthesia (author's transl)].
    Kubota M, Gotho Y, Furukawa K.
    Masui; 1979 Aug; 28(8):797-804. PubMed ID: 43404
    [No Abstract] [Full Text] [Related]

  • 6. Cardiac effects of beta-adrenergic receptor antagonists.
    Ablad B, Carlsson B, Carlsson E, Dahlöf C, Ek L, Hultberg E.
    Adv Cardiol; 1974 Aug; 12(0):290-302. PubMed ID: 4151859
    [No Abstract] [Full Text] [Related]

  • 7. Beta adrenergic blocking and cardiovascular properties of two new substances, Kö 1313 and Kö 1366.
    Baum T, Rowles G, Shropshire AT, Gluckman MI.
    J Pharmacol Exp Ther; 1971 Feb; 176(2):339-49. PubMed ID: 4398186
    [No Abstract] [Full Text] [Related]

  • 8. Cardiac actions of oxprenolol as studied in dog heart-lung preparations.
    Takeda K, Iizuka H, Imai S.
    Arzneimittelforschung; 1973 Oct; 23(10):1446-50. PubMed ID: 4149692
    [No Abstract] [Full Text] [Related]

  • 9. Comparative study of beta andreoceptor antagonists on the isolated atria of control and of the reserpine treated rabbits.
    Hague MA, Darabi MK, Khalighi MR.
    Pahlavi Med J; 1977 Jul; 8(3):326-44. PubMed ID: 21372
    [Abstract] [Full Text] [Related]

  • 10. Protection against isoprenaline induced myocardial necroses by beta-adrenergic blocking agents.
    Kulig A, Kostka-Trabka E, Gryglewski R.
    Pol J Pharmacol Pharm; 1973 Jul; 25(1):85-90. PubMed ID: 4149575
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacodynamic properties of beta-adrenergic receptor blocking drugs in man.
    Gibson DG.
    Drugs; 1974 Jul; 7(1):8-38. PubMed ID: 4151693
    [No Abstract] [Full Text] [Related]

  • 12. Direct myocardial depressant effects of several beta-adrenergic blocking agents in the unanesthetized atherosclerotic rabbit.
    Lee RJ, Dickerson DD, Fulmor IE, Goldberg ME.
    Proc Soc Exp Biol Med; 1978 Jun; 158(2):147-50. PubMed ID: 27818
    [No Abstract] [Full Text] [Related]

  • 13. Pulmonary vascular and cardiac effects of glucagon before and after adrenergic beta-receptor blockade.
    Madan BR, Gupta RS, Jain BK.
    Indian J Physiol Pharmacol; 1971 Oct; 15(4):173-7. PubMed ID: 4401547
    [No Abstract] [Full Text] [Related]

  • 14. [Beta adrenergic drugs in arterial hypertension].
    Gysling E.
    Union Med Can; 1972 Jul; 101(7):1336-41. PubMed ID: 4402882
    [No Abstract] [Full Text] [Related]

  • 15. Cardiovascular effects of beta-adrenoreceptor blocking agents after intracerebroventricular administration in conscious normotensive cats.
    Day MD, Roach AG.
    Clin Exp Pharmacol Physiol; 1974 Jul; 1(4):333-9. PubMed ID: 4156505
    [No Abstract] [Full Text] [Related]

  • 16. Cardiovascular effects of prinodolol (LB-46), a potent beta-adrenergic receptor antagonist.
    Levy JV.
    J Clin Pharmacol New Drugs; 1971 Jul; 11(4):249-60. PubMed ID: 4397374
    [No Abstract] [Full Text] [Related]

  • 17. Nutritional circulation in the heart. 3. Effect of isoproterenol and beta adrenergic blockade on myocardial hemodynamics and rubicium-86 extraction in the isolated supported heart preparation.
    Somani P, Laddu AR, Hardm HF.
    J Pharmacol Exp Ther; 1970 Dec; 175(3):577-92. PubMed ID: 4395225
    [No Abstract] [Full Text] [Related]

  • 18. The central action of drugs affecting beta-adrenergic receptor. IV. The influence of intraventricularly administered drugs affecting beta-adrenergic receptor on blood pressure in rats.
    Kleinrok Z, Ksiazek A.
    Pol J Pharmacol Pharm; 1975 Dec; 27(2):177-82. PubMed ID: 239397
    [Abstract] [Full Text] [Related]

  • 19. Selective beta adrenergic receptor antagonism in the anesthetized dog.
    Wasserman MA, Levy B.
    J Pharmacol Exp Ther; 1974 Feb; 188(2):357-67. PubMed ID: 4149462
    [No Abstract] [Full Text] [Related]

  • 20. Analysis of the hemodynamic action of beta-adrenolytics in narcotized cats.
    Górka Z.
    Acta Med Pol; 1973 Feb; 14(1):7-26. PubMed ID: 4144422
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.